Sunday, 16 June 2019

China News

  • ShangPharma completes in-house merger

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Mar, 2013

    Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology R&D outsourcing company, has completed the merger contemplated by the previously announced agreement and p...Read more

  • China CRO facility undergoes US FDA inspection

    China |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

    Singapore: For the first time, the US FDA has completed an inspection in China under its combined clinical trial and bioresearch monitoring program. Frontage Laboratories, a pharmaceutical...Read more

  • Why does NYSE want to delist China Botanic?

    China |  News | By BioSpectrum Bureau  | 0 Comment | 06 Feb, 2013

    Singapore: China Botanic Pharmaceutical received a notice of failure to satisfy continued listing standards from the New York Stock Exchange (NYSE) stock exchange. NYSE had previously warne...Read more

  • China's national vaccine production base takes safety enhancement measures

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2014

    Singapore: UK based UV disinfection specialist Hanovia has supplied three UV water disinfection systems, PharmaLine PQL, to the Institute of Medical Biology of Chinese Academy of Sciences i...Read more

  • Mindray to acquire ZONARE Medical Systems

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Mindray Medical International has announced a definitive agreement to acquire ZONARE Medical Systems (Zonare), an ultrasound technology leader in the high-end radiology segment, ...Read more

  • Is China bioscience really slowing down?

    China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Is China bioscience slowing down? From the numbers that have been put together by the BioSpectrum Asia Pacific Bioscience Industry Survey 2013, it does look so. However, a little deeper loo...Read more

  • US-based TriReme looks for big growth in Asia

    China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    TriReme Medical, a US-based start-up medical devices company dedicated to the development and manufacturing of innovative devices for the treatment of complex vascular disease, recently ope...Read more

  • Pharma Logistics China from October 23

    China |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2012

    Singapore: The 2nd Pharma Logistics China 2012 will be held from October 23 till October 25 at Shanghai, China. The conference is the foremost and only gathering of heads from leading biot...Read more

  • Takeda diabetes drug gets China's import license

    China |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: China's State Food and Drug Administration (SFDA) issued an Import Drug License (IDL) for Takeda's type 2 diabetes drug Nesina (alogliptin). Orally administered dipeptidyl pept...Read more

  • WHO confirms new H7N9 cases

    China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2014

    Singapore: Even as China reported eight new cases of H7N9 earlier this week, the World Health Organization has posted two updates on these cases. WHO's first update spoke of the new human ...Read more

  • Menarini to market Moberg nails in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: Menarini Asia Pacific has been granted exclusive rights to market and sell Moberg Pharma's Kerasal Nail in China. The companies now intend to seek marketing authorization for the...Read more

  • Dr Ling Su is new DIA board president

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Singapore: DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide, has appointed Dr Ling Su as the presi...Read more

  • BGI-Shenzhen extends acquisition date of Complete

    China |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

    Singapore: BGI-Shenzhen's wholly owned subsidiary, Beta Acquisition, extended its all cash tender offer to purchase all outstanding shares of common stock of US-based Complete Genomics to 1...Read more

  • 3SBio to merge with Decade Sunshine

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2013

    Singapore: China-based 3SBio entered into an agreement and plan-of-merger with Decade Sunshine, an exempted company with limited liability incorporated under the laws of the Cayman Islands...Read more

  • APAC healthcare industry becomes cloud friendly

    China |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is embracing the full gamut of cloud provided services from infrastructure...Read more

  • Material science firm Crystal to open lab in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

    Singapore: Crystal Pharmatech is going to open its laboratories in China in order to provide customized, materials science development service packages in drug R&D. Crystal has adopte...Read more

  • Mindray re-elects its directors

    China |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

    Singapore: Shareholders of Mindray Medical, a leading developer, manufacturer and marketer of medical devices, have re-elected its directors Mr Xu Hang, Mr Ronald Ede and Mr Chen Qingtai. E...Read more

  • Life Tech Sanger sequencer gets China SFDA nod

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Mar, 2013

    Singapore: Life Technologies announced that its Applied Biosystems 3500xL Dx Genetic Analyzer has been approved by China's State Food and Drug Administration (SFDA) for clinical diagnostic...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls